A NOVEL ENEDIYNE PRODRUG FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) USING ESCHERICHIA-COLI-B NITROREDUCTASE

被引：43

作者：

HAY, MP

WILSON, WR

DENNY, WA

机构：

[1] UNIV AUCKLAND,SCH MED,CANC RES LAB,AUCKLAND,NEW ZEALAND

[2] UNIV AUCKLAND,SCH MED,ONCOL SECT,AUCKLAND,NEW ZEALAND

[3] UNIV AUCKLAND,SCH MED,DEPT PATHOL,AUCKLAND,NEW ZEALAND

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1995年 / 5卷 / 23期

关键词：

D O I：

10.1016/0960-894X(95)00495-F

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis of a novel enediyne 2, and its cytotoxicity and activation by the nitroreductase enzyme NR2 from Esherichia coli B, are described. In contrast to closely related analogues, 2 exhibits a 90-fold increase in cytoxicity against UV4 cells in the presence of the enzyme and NADH, suggesting its potential as a prodrug for Antibody-Directed Enzyme Prodrug Therapy in conjunction with E. coli nitroreductase.

引用

收藏

页码：2829 / 2834

页数：6

相关论文

共 21 条

[1] THE BIOACTIVATION OF 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE (CB1954) .1. PURIFICATION AND PROPERTIES OF A NITROREDUCTASE ENZYME FROM ESCHERICHIA-COLI - A POTENTIAL ENZYME FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) [J].

ANLEZARK, GM ;

MELTON, RG ;

SHERWOOD, RF ;

COLES, B ;

FRIEDLOS, F ;

KNOX, RJ .

BIOCHEMICAL PHARMACOLOGY, 1992, 44 (12) :2289-2295

[2] BIOACTIVATION OF DINITROBENZAMIDE MUSTARDS BY AN ESCHERICHIA-COLI-B NITROREDUCTASE [J].

ANLEZARK, GM ;

MELTON, RG ;

SHERWOOD, RF ;

WILSON, WR ;

DENNY, WA ;

PALMER, BD ;

KNOX, RJ ;

FRIEDLOS, F ;

WILLIAMS, A .

BIOCHEMICAL PHARMACOLOGY, 1995, 50 (05) :609-618

[3] ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY [J].

BAGSHAWE, KD .

CLINICAL PHARMACOKINETICS, 1994, 27 (05) :368-376

[4] REACTIVE 1,4-DEHYDROAROMATICS [J].

BERGMAN, RG .

ACCOUNTS OF CHEMICAL RESEARCH, 1973, 6 (01) :25-31

[5] SITE-SPECIFIC ATOM TRANSFER FROM DNA TO A BOUND LIGAND DEFINES THE GEOMETRY OF A DNA CALICHEAMICIN GAMMA-1I COMPLEX [J].

DEVOSS, JJ ;

TOWNSEND, CA ;

DING, WD ;

MORTON, GO ;

ELLESTAD, GA ;

ZEIN, N ;

TABOR, AB ;

SCHREIBER, SL .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (26) :9669-9670

[6]

GOLICK J, 1987, J AM CHEM SOC, V109, P3463

[7] TUMOR TARGETING - ACTIVATION OF PRODRUGS BY ENZYME-MONOCLONAL ANTIBODY CONJUGATES [J].

HUENNEKENS, FM .

TRENDS IN BIOTECHNOLOGY, 1994, 12 (06) :234-239

[8] THE BIOACTIVATION OF 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE (CB1954) .2. A COMPARISON OF AN ESCHERICHIA-COLI NITROREDUCTASE AND WALKER DT DIAPHORASE [J].

KNOX, RJ ;

FRIEDLOS, F ;

SHERWOOD, RF ;

MELTON, RG ;

ANLEZARK, GM .

BIOCHEMICAL PHARMACOLOGY, 1992, 44 (12) :2297-2301

[9] THE BIOACTIVATION OF CB-1954 AND ITS USE AS A PRODRUG IN ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) [J].

KNOX, RJ ;

FRIEDLOS, F ;

BOLAND, MP .

CANCER AND METASTASIS REVIEWS, 1993, 12 (02) :195-212

[10] CALICHEMICINS, A NOVEL FAMILY OF ANTITUMOR ANTIBIOTICS .1. CHEMISTRY AND PARTIAL STRUCTURE OF CALICHEMICIN-GAMMA-1 [J].

LEE, MD ;

DUNNE, TS ;

SIEGEL, MM ;

CHANG, CC ;

MORTON, GO ;

BORDERS, DB .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (11) :3464-3466